CROX leans on bold innovation, new franchises, and standout sandal momentum to fuel global demand and drive long-term growth.
Crocs faces ongoing sales and earnings declines, driven by North American weakness and shifting consumer preferences, but trades at a low forward P/E of 6. Despite business headwinds, CROX maintains premium margins and strong international growth, especially in China, Japan, and Western Europe, partially offsetting U.S. softness. Shareholder-friendly capital allocation, including buybacks and debt reduction, supports a potential turnaround if business erosion slows and margins hold.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Crocs is downgraded to a sell as both its core and HEYDUDE brands face declining sales and worsening outlooks. CROX struggles with weak consumer demand, ineffective promotions, margin erosion, and a heavy debt load, despite cost-cutting initiatives. Q3 results showed revenue down 6.2% year-over-year, with further declines and margin compression expected in the critical holiday quarter.
Crocs, Inc. ( CROX ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Erinn Murphy - Senior VP of Investor Relations & Corporate Strategy Andrew Rees - CEO, Director & Interim President for HEYDUDE Brand Patraic Reagan - Executive VP & CFO Conference Call Participants Jonathan Komp - Robert W. Baird & Co. Incorporated, Research Division Christopher Nardone - BofA Securities, Research Division Tom Nikic - Needham & Company, LLC, Research Division Adrienne Yih-Tennant - Barclays Bank PLC, Research Division Peter McGoldrick - Stifel, Nicolaus & Company, Incorporated, Research Division Rakesh Patel - Raymond James & Associates, Inc., Research Division Jay Sole - UBS Investment Bank, Research Division Brooke Roach - Goldman Sachs Group, Inc., Research Division Aubrey Tianello - BNP Paribas, Research Division Anna Andreeva - Piper Sandler & Co., Research Division Presentation Operator Good morning, and welcome to the Crocs, Inc. Third Quarter 2025 Earnings Conference Call.
Shares of Crocs Inc. fell Thursday after sales of the footwear maker's namesake brand declined for the first time in five years — and are expected to continue falling as customers continue to be more selective in spending their money.
CROX posts better-than-expected Q3 earnings and sales despite year-over-year declines, aided by cost controls and brand execution.
The headline numbers for Crocs (CROX) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Crocs (CROX) came out with quarterly earnings of $2.92 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $3.6 per share a year ago.
Crocs reported lower third-quarter profit and sales as demand for its namesake brand continues to fall from prior years.
Beyond analysts' top-and-bottom-line estimates for Crocs (CROX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
CROX faces persistent HEYDUDE softness amid tariffs and weak U.S. demand, but core clogs, sandals and DTC growth offer some resilience.